Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_assertion type Assertion NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_head.
- NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_assertion description "[The objective of this study was to investigate whether tumor derived fibronectin alternatively spliced EDA domain has a lymphangiogenic potency on human lymphatic endothelial cells (LECs) in tumor generation to facilitate tumor lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_provenance.
- NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_assertion evidence source_evidence_literature NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_provenance.
- NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_assertion SIO_000772 20023414 NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_provenance.
- NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_assertion wasDerivedFrom befree-2016 NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_provenance.
- NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_assertion wasGeneratedBy ECO_0000203 NP782597.RAZdHgsX1pVo7_lGXZvSrVCsEGnTp_GrLCv7YUKgDSX3o130_provenance.